These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

800 related items for PubMed ID: 16889577

  • 21. Determination of risk factors for Epstein-Barr virus-associated posttransplant lymphoproliferative disorder in pediatric liver transplant recipients using objective case ascertainment.
    Guthery SL, Heubi JE, Bucuvalas JC, Gross TG, Ryckman FC, Alonso MH, Balistreri WF, Hornung RW.
    Transplantation; 2003 Apr 15; 75(7):987-93. PubMed ID: 12698085
    [Abstract] [Full Text] [Related]

  • 22. B lymphocytes and Epstein-Barr virus: the lesson of post-transplant lymphoproliferative disorders.
    Dolcetti R.
    Autoimmun Rev; 2007 Dec 15; 7(2):96-101. PubMed ID: 18035317
    [Abstract] [Full Text] [Related]

  • 23. Tumor origin and CD20 expression in posttransplant lymphoproliferative disorder occurring in solid organ transplant recipients: implications for immune-based therapy.
    Gulley ML, Swinnen LJ, Plaisance KT, Schnell C, Grogan TM, Schneider BG, Southwest Oncology Group.
    Transplantation; 2003 Sep 27; 76(6):959-64. PubMed ID: 14508361
    [Abstract] [Full Text] [Related]

  • 24. Incidence and consequences of post-transplantation lymphoproliferative disorders.
    Boubenider S, Hiesse C, Goupy C, Kriaa F, Marchand S, Charpentier B.
    J Nephrol; 1997 Sep 27; 10(3):136-45. PubMed ID: 9238621
    [Abstract] [Full Text] [Related]

  • 25. Post-transplant lymphoproliferative disorder: a review.
    Loren AW, Porter DL, Stadtmauer EA, Tsai DE.
    Bone Marrow Transplant; 2003 Feb 27; 31(3):145-55. PubMed ID: 12621474
    [Abstract] [Full Text] [Related]

  • 26. Immunotherapy for Epstein-Barr virus-associated malignancies.
    Long HM, Parsonage G, Fox CP, Lee SP.
    Drug News Perspect; 2010 May 27; 23(4):221-8. PubMed ID: 20520851
    [Abstract] [Full Text] [Related]

  • 27. Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantation.
    Hurwitz M, Desai DM, Cox KL, Berquist WE, Esquivel CO, Millan MT.
    Pediatr Transplant; 2004 Jun 27; 8(3):267-72. PubMed ID: 15176965
    [Abstract] [Full Text] [Related]

  • 28. Induction of pre-transplant Epstein-Barr virus (EBV) infection by donor blood transfusion in EBV-seronegative recipients may reduce risk of post-transplant lymphoproliferative disease in adolescent renal transplant patients: report of two cases.
    Babel N, Gabdrakhmanova L, Hammer M, Rosenberger C, Oppert M, Volk HD, Reinke P.
    Transpl Infect Dis; 2005 Jun 27; 7(3-4):133-6. PubMed ID: 16390402
    [Abstract] [Full Text] [Related]

  • 29. Epstein-Barr virus-associated lymphoproliferative disease after allogeneic haematopoietic stem cell transplantation: molecular monitoring and early treatment of high-risk patients.
    Meijer E, Cornelissen JJ.
    Curr Opin Hematol; 2008 Nov 27; 15(6):576-85. PubMed ID: 18832928
    [Abstract] [Full Text] [Related]

  • 30. Epstein-Barr virus-related post-transplant lymphoproliferative disorder in solid organ transplant recipients.
    San-Juan R, Comoli P, Caillard S, Moulin B, Hirsch HH, Meylan P, ESCMID Study Group of Infection in Compromised Hosts.
    Clin Microbiol Infect; 2014 Sep 27; 20 Suppl 7():109-18. PubMed ID: 24475976
    [Abstract] [Full Text] [Related]

  • 31. Determining virological, serological and immunological parameters of EBV infection in the development of PTLD.
    Davis JE, Sherritt MA, Bharadwaj M, Morrison LE, Elliott SL, Kear LM, Maddicks-Law J, Kotsimbos T, Gill D, Malouf M, Falk MC, Khanna R, Moss DJ.
    Int Immunol; 2004 Jul 27; 16(7):983-9. PubMed ID: 15159377
    [Abstract] [Full Text] [Related]

  • 32. Epstein-Barr viral load in whole blood of adults with posttransplant lymphoproliferative disorder after solid organ transplantation does not correlate with clinical course.
    Oertel S, Trappe RU, Zeidler K, Babel N, Reinke P, Hummel M, Jonas S, Papp-Vary M, Subklewe M, Dörken B, Riess H, Gärtner B.
    Ann Hematol; 2006 Jul 27; 85(7):478-84. PubMed ID: 16586109
    [Abstract] [Full Text] [Related]

  • 33. Occurrence of post-transplant lymphoproliferative disorders among over thousand adult recipients: any role for hepatitis C infection?
    Burra P, Buda A, Livi U, Rigotti P, Zanus G, Calabrese F, Caforio A, Menin C, Canova D, Farinati F, Luciana Aversa SM.
    Eur J Gastroenterol Hepatol; 2006 Oct 27; 18(10):1065-70. PubMed ID: 16957512
    [Abstract] [Full Text] [Related]

  • 34. Evidence for genetic susceptibility towards development of posttransplant lymphoproliferative disorder in solid organ recipients.
    Babel N, Vergopoulos A, Trappe RU, Oertel S, Hammer MH, Karaivanov S, Schneider N, Riess H, Papp-Vary M, Neuhaus R, Gondek LP, Volk HD, Reinke P.
    Transplantation; 2007 Aug 15; 84(3):387-91. PubMed ID: 17700165
    [Abstract] [Full Text] [Related]

  • 35. Utility of semiquantitative polymerase chain reaction for Epstein-Barr virus to measure virus load in pediatric organ transplant recipients with and without posttransplant lymphoproliferative disease.
    Allen U, Hebert D, Petric M, Tellier R, Tran D, Superina R, Stephens D, West L, Wasfy S, Nelson S.
    Clin Infect Dis; 2001 Jul 15; 33(2):145-50. PubMed ID: 11418872
    [Abstract] [Full Text] [Related]

  • 36. [Latest update on immunotherapy of Epstein-Barr virus-associated post-transplantation lymphoproliferative disease].
    Hao QF, Sheng GY, Luan Z.
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Sep 15; 15(9):795-9. PubMed ID: 24034931
    [Abstract] [Full Text] [Related]

  • 37. Post-transplant lymphoproliferative disorders, Epstein-Barr virus infection, and disease in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.
    Allen UD, Preiksaitis JK, AST Infectious Diseases Community of Practice.
    Clin Transplant; 2019 Sep 15; 33(9):e13652. PubMed ID: 31230381
    [Abstract] [Full Text] [Related]

  • 38. Adenotonsillar hypertrophy and Epstein-Barr virus in pediatric organ transplant recipients.
    Shapiro NL, Strocker AM.
    Laryngoscope; 2001 Jun 15; 111(6):997-1001. PubMed ID: 11404611
    [Abstract] [Full Text] [Related]

  • 39. Post-transplant lymphoproliferative disorders. Molecular analysis of histogenesis and pathogenesis.
    Capello D, Berra E, Cerri M, Gaidano G.
    Minerva Med; 2004 Feb 15; 95(1):53-64. PubMed ID: 15041926
    [Abstract] [Full Text] [Related]

  • 40. Immune-cell treatment of Epstein--Barr-virus-associated lymphoproliferative disorders.
    Swinnen LJ.
    Best Pract Res Clin Haematol; 2006 Feb 15; 19(4):839-47. PubMed ID: 16997187
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 40.